Novonesis (Novozymes A/S) (NVZMY)
57.83
+0.11
(+0.19%)
USD |
OTCM |
May 19, 16:00
Novonesis (Novozymes A/S) Shareholders Equity (Quarterly) : 12.58B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| RPM International, Inc. | 3.147B |
| Givaudan SA | -- |
| Symrise AG | -- |
| DSM-Firmenich AG | -- |
| Arq, Inc. | 167.81M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.04B |
| Total Liabilities (Quarterly) | 6.457B |
| Debt to Equity Ratio | 0.2942 |
| Current Ratio | 1.674 |
| Net Debt Paydown Yield | -1.32% |